CN1233341C - Medicine compositions for treating LIDP - Google Patents
Medicine compositions for treating LIDP Download PDFInfo
- Publication number
- CN1233341C CN1233341C CN 01135176 CN01135176A CN1233341C CN 1233341 C CN1233341 C CN 1233341C CN 01135176 CN01135176 CN 01135176 CN 01135176 A CN01135176 A CN 01135176A CN 1233341 C CN1233341 C CN 1233341C
- Authority
- CN
- China
- Prior art keywords
- weight portions
- radix
- pharmaceutical composition
- rhizoma atractylodis
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention provides a medicinal composition for curing lumbar intervertebral disk protrusion, which is parpared from the following traditional Chinese medicines of the proportion: astragalus roots, radix codonopsitis, rhizoma atractylodis macrocephalae, poria from Yunnan of China, angelica, radix salviae miltiorrhizae, rhizoma atractylodis, pericarpium citri reticulatae, etc. The medicinal composition has the advantages of the good curative effects, high cure rate, obvious effects, relief of pain brought by traction to patients and reduction of the high curing cost.
Description
Technical field
The invention provides a kind of Chinese medicine pharmaceutical composition, particularly treat the pharmaceutical composition of prolapse of lumbar intervertebral disc.
Background technology
Prolapse of lumbar intervertebral disc is a kind of commonly encountered diseases, frequently-occurring disease.The method one of this disease of existing treatment is a non-operative treatment, and promptly patient's hardboard bed for sleeping in is had a rest; Carry out traction of pelvis along the longitudinal axis, epidural space sealing is rubbed by, traction, manipulation of carrying on the back and is tiltedly removed side and remove, the waist that quivers, tension and compression and paravertebral muscles sealing etc.; The 2nd, operative therapy, invalid to non-operative treatment, but obviously or repeatedly outbreak of symptom has a strong impact on work and gives birth to the reviver, can excise vertebral plate through the way of escape, extract outstanding intervertebral disc, or extract the pathological interspinal dish through preceding road, the row bone graft fusion.The non-operative treatment curative effect is not obvious, and the operative therapy patient is painful big, and cost is many, recovers slow.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of pharmaceutical composition for the treatment of prolapse of lumbar intervertebral disc, to improve therapeutic effect, the misery when alleviating patient.
The present invention is achieved in that a kind of pharmaceutical composition for the treatment of prolapse of lumbar intervertebral disc, and described pharmaceutical composition is made up of following medicine:
The Radix Astragali 20～35 weight portions
Radix Codonopsis 20～35 weight portions
The Rhizoma Atractylodis Macrocephalae 9～20 weight portions
Poria 9～20 weight portions
Radix Angelicae Sinensis 10～30 weight portions
Radix Salviae Miltiorrhizae 12～30 weight portions
Rhizoma Atractylodis 9～20 weight portions
Pericarpium Citri Reticulatae 6～12 weight portions
Cortex Phellodendri 6～20 weight portions
Radix Saposhnikoviae 9～20 weight portions
Rhizoma Chuanxiong 6～18 weight portions
Radix Paeoniae Rubra 5～12 weight portions
The Radix Paeoniae Alba 10～35 weight portions
Ramulus Cinnamomi 3～10 weight portions
Semen Persicae 3～15 weight portions
Flos Carthami 3～15 weight portions
Radix Glycyrrhizae 6～20 weight portions
A kind of pharmaceutical composition for the treatment of prolapse of lumbar intervertebral disc, the optimum ratio scope of described pharmaceutical composition is:
The Radix Astragali 20～30 weight portions
Radix Codonopsis 20～30 weight portions
The Rhizoma Atractylodis Macrocephalae 10～15 weight portions
Poria 10～15 weight portions
Radix Angelicae Sinensis 20～30 weight portions
Radix Salviae Miltiorrhizae 15～30 weight portions
Rhizoma Atractylodis 10～15 weight portions
Pericarpium Citri Reticulatae 8～10 weight portions
Cortex Phellodendri 8～15 weight portions
Radix Saposhnikoviae 10～15 weight portions
Rhizoma Chuanxiong 10～15 weight portions
Radix Paeoniae Rubra 6～10 weight portions
The Radix Paeoniae Alba 15～25 weight portions
Ramulus Cinnamomi 6～10 weight portions
Semen Persicae 6～10 weight portions
Flos Carthami 6～10 weight portions
Radix Glycyrrhizae 10～15 weight portions
A kind of pharmaceutical composition for the treatment of prolapse of lumbar intervertebral disc, the best proportioning of described pharmaceutical composition is:
The Radix Astragali 20 weight portions
Radix Codonopsis 25 weight portions
The Rhizoma Atractylodis Macrocephalae 10 weight portions
Poria 10 weight portions
Radix Angelicae Sinensis 20 weight portions
Radix Salviae Miltiorrhizae 25 weight portions
Rhizoma Atractylodis 10 weight portions
Pericarpium Citri Reticulatae 9 weight portions
Cortex Phellodendri 8 weight portions
Radix Saposhnikoviae 10 weight portions
Rhizoma Chuanxiong 10 weight portions
Radix Paeoniae Rubra 8 weight portions
The Radix Paeoniae Alba 20 weight portions
Ramulus Cinnamomi 6 weight portions
Semen Persicae 6 weight portions
Flos Carthami 6 weight portions
Radix Glycyrrhizae 10 weight portions
The pharmaceutical composition of this treatment prolapse of lumbar intervertebral disc, therapeutic effect is good, the cure rate height, instant effect has been removed the misery that traction, operative treatment bring to patient from, and high medical expense.The treatment femur head necrosis also there is certain curative effect.
The specific embodiment
Further specify the present invention below.
The present invention's pharmaceutical composition fried, instructions of taking is identical with other Chinese medicine pharmaceutical composition.Every agent medicine compositions is that unit is formulated by said ratio with the gram.To soak 40 minutes with cold water by every agent medicine compositions that proportioning prepares.Every dose of medicine is fried twice, whenever begins to boil 40 minutes all over the boiling of the water in frying pan.After first pass has boiled medicinal liquid is poured out, added decocting in water again second time.Remove medicinal residues, twice fried medicinal liquid that obtains lumped together drink.Two doses of every days, each potion sooner or later." dizziness,nausea " reaction can appear in period in a medicine part patient, is momentary, mostly calms down naturally at short notice.After the reaction, slight illness can alleviate rapidly or disappear.
Take through 189 routine patients and to show that this pharmaceutical composition has good curative effect to the treatment prolapse of lumbar intervertebral disc.In 189 examples, male 131 examples, women 58 examples.20～30 years old 41 age example, 31～41 years old 58 example, 90 examples more than 41 years old.
Before the treatment, each pain example is all shone the positive profile of lumbar vertebra through scanning of CT lumbar vertebra and X-ray, confirms prolapse of lumbar intervertebral disc and prolapse of lumbar intervertebral disc position.
The criterion of curative effect:
Recovery from illness: functional rehabilitation is normal, and symptom all disappears.
Effectively: function is recovered normally substantially, and symptom is complete obiteration not.
Invalid: symptom does not change.
Therapeutic Method is by aforementioned fried, instructions of taking treatment.20 doses of minimum clothes in 189 examples, obey 40 doses at most, on average obey 30 doses.
Through treatment, recovery from illness 176 examples account for 93.1% in 189 examples; Effective 13 examples account for 6.9%.Invalid 0 example.
The effect of the present invention's pharmaceutical composition is sweet temperature QI invigorating, heat clearing and damp drying, blood circulation promoting and blood stasis dispelling, wind-expelling pain-stopping.Cure mainly: lumbar strain or damage; Wind, wet, heat are invaded waist, pent-up do not loose the wind of fighting mutually with QI and blood and forming, wet, hot lumbago.
In the present invention's the pharmaceutical composition, the Radix Astragali, Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, the sweet temperature QI invigorating of Poria, wherein Radix Astragali tonifying Qi and lifting yang is used for blood stasis due to qi deficiency, controls arthralgia due to stagnation of blood, and the capable then blood of gas is capable; The Radix Codonopsis invigorating the spleen and replenishing QI can QI invigorating, can enrich blood again, and deficiency of vital energy blood deficiency all can be used; Rhizoma Atractylodis Macrocephalae sweetness and bitterness is warm in nature, in the sweet temperature compensation, but hardship dampness; Poria is sweet light and flat, and Gan Zeneng mends, and lightly then can ooze, and can set upright (spleen, suffer from a deficiency of the kidney), again can eliminating evil (the wet Sheng).Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, Radix Paeoniae Rubra blood circulation promoting and blood stasis dispelling, wherein the Radix Angelicae Sinensis promoting blood circulation and stopping pain is used for rheumatism numbness and aches, and sweet benefit is hot looses, and can invigorate blood circulation, and can enrich blood again; The Radix Salviae Miltiorrhizae blood circulation promoting and blood stasis dispelling, detumescence relieves the pain, and is used for the pyretic arthralgia joint, and the muscle stasis of blood that swells can be enriched blood; The Rhizoma Chuanxiong blood-activating and qi-promoting, dispeling the wind relieves the pain, and is used for arthritis pain, anemofrigid-damp arthralgia; The Radix Paeoniae Rubra cool the blood dissipate blood stasis is controlled wet, the hot stasis of blood and is stagnated.The Radix Paeoniae Alba, the sweet temperature QI invigorating of Radix Glycyrrhizae, emergency relieve the pain.Semen Persicae, Flos Carthami blood circulation promoting and blood stasis dispelling stimulate the menstrual flow, and it is painful to control wind, arthralgia chiefly caused by damp pathogen.The Ramulus Cinnamomi promoting the flow of QI-blood by warming the meridian.More than all medicines match with Rhizoma Atractylodis, Pericarpium Citri Reticulatae, Cortex Phellodendri, Radix Saposhnikoviae, be used for the treatment of prolapse of lumbar intervertebral disc, can play better curative effect.
Claims (3)
1, a kind of pharmaceutical composition for the treatment of prolapse of lumbar intervertebral disc is characterized in that, described pharmaceutical composition is made up of following medicine:
The Radix Astragali 20～35 weight portions
Radix Codonopsis 20～35 weight portions
The Rhizoma Atractylodis Macrocephalae 9～20 weight portions
Poria 9～20 weight portions
Radix Angelicae Sinensis 10～30 weight portions
Radix Salviae Miltiorrhizae 12～30 weight portions
Rhizoma Atractylodis 9～20 weight portions
Pericarpium Citri Reticulatae 6～12 weight portions
Cortex Phellodendri 6～20 weight portions
Radix Saposhnikoviae 9～20 weight portions
Rhizoma Chuanxiong 6～18 weight portions
Radix Paeoniae Rubra 5～12 weight portions
The Radix Paeoniae Alba 10～35 weight portions
Ramulus Cinnamomi 3～10 weight portions
Semen Persicae 3～15 weight portions
Flos Carthami 3～15 weight portions
Radix Glycyrrhizae 6～20 weight portions
2, a kind of pharmaceutical composition for the treatment of prolapse of lumbar intervertebral disc as claimed in claim 1 is characterized in that the ratio range of described pharmaceutical composition is:
The Radix Astragali 20～30 weight portions
Radix Codonopsis 20～30 weight portions
The Rhizoma Atractylodis Macrocephalae 10～15 weight portions
Poria 10～15 weight portions
Radix Angelicae Sinensis 20～30 weight portions
Radix Salviae Miltiorrhizae 15～30 weight portions
Rhizoma Atractylodis 10～15 weight portions
Pericarpium Citri Reticulatae 8～10 weight portions
Cortex Phellodendri 8～15 weight portions
Radix Saposhnikoviae 10～15 weight portions
Rhizoma Chuanxiong 10～15 weight portions
Radix Paeoniae Rubra 6～10 weight portions
The Radix Paeoniae Alba 15～25 weight portions
Ramulus Cinnamomi 6～10 weight portions
Semen Persicae 6～10 weight portions
Flos Carthami 6～10 weight portions
Radix Glycyrrhizae 10～15 weight portions
3, a kind of pharmaceutical composition for the treatment of prolapse of lumbar intervertebral disc as claimed in claim 1 is characterized in that the proportioning of described pharmaceutical composition is:
The Radix Astragali 20 weight portions
Radix Codonopsis 25 weight portions
The Rhizoma Atractylodis Macrocephalae 10 weight portions
Poria 10 weight portions
Radix Angelicae Sinensis 20 weight portions
Radix Salviae Miltiorrhizae 25 weight portions
Rhizoma Atractylodis 10 weight portions
Pericarpium Citri Reticulatae 9 weight portions
Cortex Phellodendri 8 weight portions
Radix Saposhnikoviae 10 weight portions
Rhizoma Chuanxiong 10 weight portions
Radix Paeoniae Rubra 8 weight portions
The Radix Paeoniae Alba 20 weight portions
Ramulus Cinnamomi 6 weight portions
Semen Persicae 6 weight portions
Flos Carthami 6 weight portions
Radix Glycyrrhizae 10 weight portions
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01135176 CN1233341C (en) | 2001-11-14 | 2001-11-14 | Medicine compositions for treating LIDP |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01135176 CN1233341C (en) | 2001-11-14 | 2001-11-14 | Medicine compositions for treating LIDP |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1418649A CN1418649A (en) | 2003-05-21 |
| CN1233341C true CN1233341C (en) | 2005-12-28 |
Family
ID=4673013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 01135176 Expired - Fee Related CN1233341C (en) | 2001-11-14 | 2001-11-14 | Medicine compositions for treating LIDP |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1233341C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102488785A (en) * | 2011-12-16 | 2012-06-13 | 王自元 | Drug used for treating protrusion of lumbar intervertebral disc |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100998681B (en) * | 2006-01-13 | 2010-12-08 | 许定高 | Traditional Chinese medicine composition for treating prolapse of lumbar intervertebral disc shift |
| CN102552705B (en) * | 2011-11-19 | 2013-11-27 | 李永开 | Traditional Chinese medicinal capsule for treating lumbar disc herniation and femoral head necrosis |
| CN105641248A (en) * | 2015-12-31 | 2016-06-08 | 丁伟杰 | Traditional Chinese medicine composition capable of treating lumbar disc herniation and preparation method thereof |
-
2001
- 2001-11-14 CN CN 01135176 patent/CN1233341C/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102488785A (en) * | 2011-12-16 | 2012-06-13 | 王自元 | Drug used for treating protrusion of lumbar intervertebral disc |
| CN102488785B (en) * | 2011-12-16 | 2013-08-07 | 王自元 | Drug used for treating protrusion of lumbar intervertebral disc |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1418649A (en) | 2003-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1857541A (en) | Plaster for treating rheumatism and osteoarthrosis | |
| CN1803187A (en) | Chinese herbal medicine for treating lumbar intervertebral disk protrusion and hyperosteogeny | |
| CN1403101A (en) | Fracture-setting silky fowl ointment and its prepn | |
| CN1084761A (en) | Bone wound medicine (gushangling) | |
| CN1586547A (en) | Medicine for treating bone wound | |
| CN101766775A (en) | Medicine for treating lumbar disc herniation and osteoproliferation | |
| CN1419927A (en) | Sieral schemes and Chinese medicine preparation for traditional Chinese medicine diagnosis and treatment of nephritis and nephropathy syndrome | |
| CN103417742A (en) | Traditional Chinese medicine for curing cervical spondylosis and lumbar intervertebral disc hernia | |
| CN1589881A (en) | Chinese medicinal prescription for treating gastropathy | |
| CN1939446A (en) | Externally-applied Chinese-medicinal composition for treating lumbago and skelalgia | |
| CN1745801A (en) | Ointment for treating spur | |
| CN1233341C (en) | Medicine compositions for treating LIDP | |
| CN1872310A (en) | Preparation of Chinese traditional medicine for treating hyperosteogeny | |
| CN1406594A (en) | Oral Chinese medicine for osteoarthritis | |
| CN103446386B (en) | A kind of Chinese medicine composition for the treatment of lumbago | |
| CN1296093C (en) | Cervical vertebrae drawing medicine bag | |
| CN1382473A (en) | Medicine for treating psychic diseases | |
| CN101061975A (en) | Medicine mat for preventing and treating cervical vertebrae diseases | |
| CN1308025C (en) | Medicine for treating paraplegia and its preparing method | |
| CN101049374A (en) | Oral liquid for treating leucoderma, and preparation method | |
| CN1076619C (en) | Moxiburning medicine for acupoint therapy | |
| CN106237125A (en) | The active medicine of wind for Demyelination | |
| CN105055636A (en) | Traditional Chinese medicine preparation for treating osteoporosis | |
| CN1850238A (en) | Medicine composition for treating backbone and joint disease | |
| CN1323709C (en) | 'Sibai' soup for health of women |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20051228 Termination date: 20171114 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |